CLINICALLY PROVE WOUND CARE.
LOWEST COST, HIGHEST QUALITY.
WHAT IS HUMAN BIOSCIENCES?
Founded in 1990, our biotechnology firm has and continues to revolutionize the wound care industry. Our proprietary collagen-based advanced wound care products have been used by medical professionals to heal millions of difficult or previously unhealable wounds around the world.
WE CREATED AN INDUSTRY…
• Founder Dr. Manoj K. Jain invented the collagen wound care process (“Kollagen™) and launched a multi-billion dollar industry.
USING PROPRIETARY METHODS…
• We manufacture our Kollagen™ wound care products at industrial scale with our own machinery and chemistry—delivering the lowest cost and highest quality.
PROBLEM:
HUNDREDS OF MILLIONS OF PEOPLE WORLDWIDE NEED ADVANCED WOUND CARE BUT CANNOT FIND AN EFFECTIVE, AFFORDABLE SOLUTION.
PROBLEM 1
More than 500 million people worldwide have wounds needing care. Americans alone spend $50 billion per year on wound care.
PROBLEM 2
With aging populations, longer lifespans and more comorbidities (i.e., diabetes), this number will increase.
PROBLEM 3 Traditional wound dressings only close 1 in 4 chronic wounds
PROBLEM 4
Typical wound care methods are antiquated; Advanced wound care technology like ours is badly needed in many regions of the world.
SOLUTION:
EVERY WOUND MATTERS. EVERY PATIENT MATTERS. EXPANDING OUR HIGH- EFFICIENCY, HIGHLY-MARGIN PLANTS WORLDWIDE HELPS SOLVE ONE OF THE GREATER PROBLEMS OF MANKIND WITH A SOLID BUSINESS MODEL.
SOLUTION 1
Our efficient high-production model allows us to treat more people rapidly, affordably, and effectively.
SOLUTION 2
Kollagen™ products are accessible to patients both in a clinical setting and in their own home. Easy to apply.
SOLUTION 3
Kollagen™ closes 95% of chronic wounds faster and at a significantly lower cost than other methods.
SOLUTION 4
A turnkey Kollagen™ plant is a reliable, profitable and rapid way to serve markets worldwide.
OPPORTUNITY & CHRONIC WOUND CARE MARKET SIZE
WELL-POSITIONED FOR KOLLAGEN™
GLOBAL CHRONIC WOUND CARE MARKET TO HIT USD 16.36 BILLION WITH 6.2% CAGR BY 2027;
PRESENCE OF SEVERAL LARGE SCALE HEALTHCARE COMPANIES WILL BODE WELL FOR MARKET GROWTH, SAYS FORTUNE BUSINESS INSIGHTS.
GLOBAL ADVANCED WOUND CARE MARKET:
GLOBAL MARKET ANALYSIS BY REGION, 2033
North America region, with a 37% market share in 2022, will display significant opportunities for the market growth over 2023-2033 owing to the technological advancements, the demand for wound care products for chronic wound treatment in the region.
GLOBAL COLLAGEN DRESSING MARKET SIZE IS POISED TO CROSS USD 2 BILLION BY THE END OF 2033, GROWING AT AN CAGR OF 7%. THE GROWTH OF THE MARKET CAN BE PRIMARILY ATTRIBUTED TO THE GROWING PREVALENCE OF ACUTE AND CHRONIC WOUNDS AMONG PEOPLE, SAYS RESEARCH NESTER.
RISING EXPORTS OF STERILE COLLAGEN SHEETS WORLDWIDE
GLOBAL MARKET ANALYSIS BY SOURCE, 2023
WHAT SETS KOLLAGEN™ APART?
COLLAGEN IS A KEY COMPONENT TO THE HUMAN BODY HEALING PROCESS. OUR PROPRIETARY MANUFACTURING PROCESS AND MACHINERIES ARE DESIGNED TO PRODUCE COLLAGEN PRODUCTS VIRTUALLY IDENTICAL TO HUMAN COLLAGEN. WE MARKET OUR PRODUCTS AS KOLLAGEN™ .
KOLLAGEN™
• KollagenTM contains functional proteins specific to tissue regeneration and thus is ACTIVE in the healing process.
• Collagen’s triple-helix form is crucial for wound healing because it maintains stability and biocompatibility while providing a natural scaffold for cell growth and retaining moisture.
OTHER COLLAGEN PRODUCTS
• Other collagen products provide ONLY a moist environment via inert materials and thus are PASSIVE in the healing process.
• Also, when collagen is hydrolyzed, its triple-helix structure breaks down into smaller peptides, reducing its stability and scaffolding capabilities.
KOLLAGEN™
A EUREKA MOMENT IN A LAB BUILDS AN INDUSTRY
HOW IT WORKS
Kollagen™ is applied directly to the wound in sheet or powder form. Wounds heal faster and with less infection and scarring.
MANUFACTURING BREAKTHROUGH
Dr. Jain and his team designed the first machines and perfected the mass production of Kollagen™ at low cost and high efficiency.
MARKET CREATION
HBS’s products are currently used in over 6,000 hospitals, wound care centers, and nursing homes and over 20,000 private physician practices in the USA. These private practices range from individual practitioners up to groups housing as many as 700 doctors each.
KOLLAGEN™
MANUFACTURING PROCESS
Shreds of bovine hides are processed using our award-winning, patented process. The addition of our Chemical Z™ and our proprietary freeze-drying process lead to the end product. Our vertical operation has low raw product costs and higher margins.
KOLLAGEN™ TECHNOLOGY
TRADITIONAL KOLLAGEN™
OUR COMPETITIVE ADVANTAGE
VERTICAL MANUFACTURING AND A MORE EFFECTIVE PRODUCT ENSURE MARKET STRENGTH
KOLLAGEN™ IS CONSISTENTLY MORE COST EFFECTIVE
RHEUMATOID VASCULITIC ULCERS
NEUTROPHIC ULCER W/ TENDON INVOLVEMENT
ISCHEMIC NEUTROPHIC ULCER
NEUTROPHIC INFECTED DIABETIC ULCER
ULCER WITH INFECTION
PRESSURE ULCERS
CRYOTHERABY FOR VERRUCA
ER SECONDARY TO OTC CORN MED APPLICATION
POST OP CHRONIC PARONYCHIA
POST OP ACUTE INFECTED PARONYCHIA
CORE PRODUCTS
MEDIFIL® II
Medifil® II is Kollagen™ in particle form. The particles have a high surface area, allowing them to effectively penetrate and deliver the maximum amount of Kollagen™ into the wound surface.
SKINTEMP® II
SkinTemp® II is Kollagen™ in sheet form. The dressings are porous collagen membranes which are designed to be permeable and breathable, with fluid control similar to skin. They are flexible, pliable, elastic, and durable for ease of application.
COLLATEK
Collatek® Gel is Kollagen™ in a viscous gel form. It encourages healing by donating moisture to the wound. Wounds heal best in a moist wound environment. Can be used with our Medifil II® collagen particles in hard-to-reach areas.
OVER THE COUNTER PRODUCTS
CELLUFIL®
Cellufil® is Kollagen™ in particle form, which makes it a highly flexible option. Cellufil® sprinkled into cuts and oddly shaped wound surfaces. The small particles are like microscopic sheets that ensure collagen will be donated to every open surface it comes in contact with.
CELLUSHEET®
Cellusheet® is Kollagen™ in sheet form, which lays perfectly onto flat, shallow wounds. It can be cut or ripped to fit the size exactly. The sheet can be tucked underneath an edge or in a small tunnel. Cellusheet® is permeable, breathable and can absorb drainage while not sticking to fragile new tissue.
VETERINARY PRODUCTS
KOLLAVET® II
COLLAGEN PARTICLES
Kollavet® II Collagen Particles deliver the maximum amount of KollagenTM filling irregular shapes and depths and more complicated injuries.
KOLLAVET® COLLAGEN SHEETS
Kollavet® collagen sheets are soft, flexible, pliable, elastic, and durable for ease of application on flat shallow open wounds.
UNITED STATES OPERATIONS
• Located in Gaithersburg, Maryland
• Full line of FDA approved products
• Manufacturing and Research Facility
INDIA OPERATIONS
• Located in Ahmedabad
• Plant commenced production in 2011
• Full line of regulatory approved products
QUESTIONS? OUR EXPERIENCED TEAM IS AVAILABLE TO MEET & DISCUSS +971 50 6462 507 USA Landline: +1 301 740 1893 940 Clopper Rd. Gaithersburg, MD 20878, USA jpgoenka@humanbiosciences.com human_biosciences humanbiosciencesincusa @BiosciencesInc humanbiosciences.com